Myhre Syndrome
Myhre Syndrome 

Diagnosing Myhre Syndrome

Myhre Syndrome is clincal diagnosed though characterisicts/ features of Myhre, then a geneticist will complete a blood test which will be analysed for the SMAD4 gene. This will confirm Myhre Syndrome.

Mutations in the SMAD4 gene cause Myhre syndrome. The SMAD4 gene provides instructions for making a protein involved in transmitting chemical signals from the cell surface to the nucleus. This signaling pathway, called the transforming growth factor beta (TGF-β) pathway, allows the environment outside the cell to affect how the cell produces other proteins. As part of this pathway, the SMAD4 protein interacts with other proteins to control the activity of particular genes. These genes influence many areas of development.

Some researchers believe that the SMAD4 gene mutations that cause Myhre syndrome impair the ability of the SMAD4 protein to attach (bind) properly with the other proteins involved in the signaling pathway. Other studies have suggested that these mutations result in an abnormally stable SMAD4 protein that remains active in the cell longer. Changes in SMAD4 binding or availability may result in abnormal signaling in many cell types, which affects development of several body systems and leads to the signs and symptoms of Myhre syndrome.

 

News

Fund Raising Events:

Snowdon Walk

Group Challenge

April 2018

 

Please donate here.